Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Qiu, Fengjun"'
Autor:
Qiu, Fengjun, Zeng, Rui, Li, Du, Ye, Tingjie, Xu, Wei, Wang, Xiaoling, Yan, Xiaofeng, Li, Hua, Hu, Xudong
Publikováno v:
In Heliyon September 2023 9(9)
Autor:
Zhang, Yujia1 (AUTHOR), Qiu, Fengjun1 (AUTHOR), Ye, Tingjie1 (AUTHOR), Lee, Sau Har2 (AUTHOR), Xu, Jiatuo1 (AUTHOR), Jia, Lingyan3 (AUTHOR), Zeng, Rui1 (AUTHOR), Wang, Xiaoling1,3 (AUTHOR), Hu, Xudong1 (AUTHOR), Yan, Xiaofeng1 (AUTHOR), Li, Hua1 (AUTHOR), Lu, Yanlin4 (AUTHOR), Jiang, Rilei1 (AUTHOR) jiangrilei@shutcm.edu.cn, Xu, Wei1 (AUTHOR) wei-xu11@tsinghua.org.cn
Publikováno v:
Stem Cell Research & Therapy. 5/12/2022, Vol. 13 Issue 1, p1-13. 13p.
Autor:
Zhang, Yujia, Qiu, Fengjun, Ye, Tingjie, Lee, Sau Har, Xu, Jiatuo, Jia, Lingyan, Zeng, Rui, Wang, Xiaoling, Hu, Xudong, Yan, Xiaofeng, Li, Hua, Lu, Yanlin, Jiang, Rilei, Xu, Wei
Additional file 9. Table S4. The HRs of the 32 candidate resistance genes in lung cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cd9e8ec0f4f7a9d3386bfde25c39f51
Autor:
Zhang, Yujia, Qiu, Fengjun, Ye, Tingjie, Lee, Sau Har, Xu, Jiatuo, Jia, Lingyan, Zeng, Rui, Wang, Xiaoling, Hu, Xudong, Yan, Xiaofeng, Li, Hua, Lu, Yanlin, Jiang, Rilei, Xu, Wei
Additional file 6. Table S1. The upregulated genes in drug transport process.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c03922fdc1f2c79e594490420d12e751
Autor:
Zhang, Yujia, Qiu, Fengjun, Ye, Tingjie, Lee, Sau Har, Xu, Jiatuo, Jia, Lingyan, Zeng, Rui, Wang, Xiaoling, Hu, Xudong, Yan, Xiaofeng, Li, Hua, Lu, Yanlin, Jiang, Rilei, Xu, Wei
Additional file 10. Table S5. The sequence of qPCR primers used in the study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d99c49c17f359258dfeb764bc9af81c1
Autor:
Zhang, Yujia, Qiu, Fengjun, Ye, Tingjie, Lee, Sau Har, Xu, Jiatuo, Jia, Lingyan, Zeng, Rui, Wang, Xiaoling, Hu, Xudong, Yan, Xiaofeng, Li, Hua, Lu, Yanlin, Jiang, Rilei, Xu, Wei
Additional file 3. Figure S3. Inhibition of ErbB receptor reversed resistance in NSCLC. (A) The cell viability of A549-CR cells treated with 1 µM afatinib combined with 4 μg/mL cisplatin for 48h, n=3. (B) The cell viability of H1299 cells treated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b4374e5369d316ed8e5189cd37cc0ec
Autor:
Zhang, Yujia, Qiu, Fengjun, Ye, Tingjie, Lee, Sau Har, Xu, Jiatuo, Jia, Lingyan, Zeng, Rui, Wang, Xiaoling, Hu, Xudong, Yan, Xiaofeng, Li, Hua, Lu, Yanlin, Jiang, Rilei, Xu, Wei
Additional file 8. Table S3. The gene symbols of the GO analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a31fd6ed6999951f5038d639a72b4fa1
Autor:
Zhang, Yujia, Qiu, Fengjun, Ye, Tingjie, Lee, Sau Har, Xu, Jiatuo, Jia, Lingyan, Zeng, Rui, Wang, Xiaoling, Hu, Xudong, Yan, Xiaofeng, Li, Hua, Lu, Yanlin, Jiang, Rilei, Xu, Wei
Additional file 7. Table S2. The downregulated genes in collagen and apical part cell function.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194dd09cd22bd32600abd84460844ce5
Autor:
Zhang, Yujia, Qiu, Fengjun, Ye, Tingjie, Lee, Sau Har, Xu, Jiatuo, Jia, Lingyan, Zeng, Rui, Wang, Xiaoling, Hu, Xudong, Yan, Xiaofeng, Li, Hua, Lu, Yanlin, Jiang, Rilei, Xu, Wei
Additional file 4. Figure S4. Inhibition of ERK signaling reversed chemoresistance in NSCLC. (A) WB detection for p-ERK1/2 and Survivin in A549-TR treated with 1 µM selumetinib for 2h. (B)The cell viability of A549-CR cells treated with 1 µM selume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb3b1c1948c4068193eeed01817118d
Autor:
Zhang, Yujia, Qiu, Fengjun, Ye, Tingjie, Lee, Sau Har, Xu, Jiatuo, Jia, Lingyan, Zeng, Rui, Wang, Xiaoling, Hu, Xudong, Yan, Xiaofeng, Li, Hua, Lu, Yanlin, Jiang, Rilei, Xu, Wei
Additional file 5. Figure S5. Downregulation of EREG re-sensitized NSCLC to chemo-drugs through ERK signaling. (A) The cell viability of shEREG-A549-CR cells treated with 4 μg/mL cisplatin for 48h, n=3. (B) The cell viability of shEREG-A549 cells tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e8f5dad0be3f6c8344f5d83d483f0e